- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Romosozumab – November 2018
Romosozumab: Injection 105 mg in 1.17 mL pre-filled pen; Evenity® - November 2018
Last updated
19 July 2019